Surmodics | SRDX - 净收入

金融业

USD

USD 178.56M

现金及等价物

USD 36.12M

USD 33.03M

USD 81.3M

USD 20.54M

USD 29.55M

股息收益率

0

USD -322K

USD 1.53M

376

EPS每股收益

USD -0.25

股本和储备

USD 118.9M

USD -11.54M

债务利息支出

USD 884K

USD 29.55M

USD 393.5M

USD -11.54M

USD -245.35M

USD -5.65M

普通股股本

USD 716K

386.18

USD -7.51M

USD 29.92M

销售和管理费用

USD 14.58M

USD 15.17M

贸易债权人

USD 2.79M

应收帐款人

USD 23.27M

	净收入	更改		日
Abbott	USD 1.78B		132M	2025-12
Align Technology	USD 135.76M		79.01M	2025-12
Anika Therapeutics	USD -4.87M		16.99M	2025-03
Arrowhead Research	USD 30.81M		54.56M	2025-12
Artivion	USD -2.29M		167K	2024-09
Baxter International	USD -1.13B		1.08B	2025-12
Boston Scientific	USD 672M		83M	2025-12
EDAP TMS	EUR -5.01M		586K	2025-09
Edwards Lifesciences	USD 91.2M		199.9M	2025-12
Haemonetics	USD 44.74M		6.06M	2025-12
Heron Therapeutics	USD -4.85M		4.39M	2024-09
J&J	USD 5.12B		36M	2025-12
Merit Medical Systems	USD 27.76M		4.83M	2025-09
Mesa Laboratories	USD -1.68M		5.1M	2024-12
Nektar Therapeutics	USD -37.06M		15.31M	2024-09
Option Care Health	USD 58.5M		6.69M	2025-12
Stryker	USD 849M		10M	2025-12
Surmodics	USD -11.54M		3.99M	2024-09
Trinity Biotech	USD -5.14M		11.82M	2025-09